These emerging therapies, including Wegovy, Mounjaro , and another option, represent a important advancement in managing type 2 hyperglycemia and promoting weight loss . They work by emulating the body’s natural incretin signal , assisting to moderate blood levels and decrease hunger . The drug has a few distinct qualities and may be suitable for